Eurasian J Med. 2017 Oct;49(3):188-192. doi: 10.5152/eurasianjmed.2017.17046.
Functional Effects of Alagebrium (ALT-711)-Isolated Rat Carotid Artery.
The Eurasian journal of medicine
Cigdem Toprak, Basar Sirmagul, Semra Yigitaslan
Affiliations
Affiliations
- Department of Pharmacology, Eski?ehir Osmangazi University School of Medicine, Eski?ehir, Turkey.
PMID: 29123442
PMCID: PMC5665628 DOI: 10.5152/eurasianjmed.2017.17046
Abstract
OBJECTIVE: In our study, the effects of glycosylated protein cross-link breaker, alagebrium was investigated on isolated rat carotid artery using myography. Alagebrium showed vasodilator effect on carotid artery rings; particularly, this effect was significantly increased in endothelium-intact rings.
MATERIALS AND METHODS: To clarify the vasodilator mechanism of alagebrium, different antagonists such as N(G)-Nitro-L-arginine methyl ester (L-NAME), glibenclamide, indomethacin, metoprolol, propranolol, tetraethylammonium, and calcium channel activator BAYK-8644 were used to reverse this effect.
RESULTS: Relaxation% responses to alagebrium were more significantly increased in intact endothelium than in denuded arteries. Blocking vasodilation related to channels (K-ATP, PGI2, BKca) and receptors (ß1, ß2) did not reverse the relaxation response to alagebrium. Vasodilator response to alagebrium was only slightly decreased after L-NAME incubation and significantly decreased after BAYK-8644 incubation.
CONCLUSION: Results of present study suggest that the mechanism of alagebrium-induced vasodilator effect may include the blockage of L-type calcium channels and partially of the nitric oxide synthase enzyme.
Keywords: Alagebrium; calcium channel blockage; carotid artery; nitric oxide; vasodilatation
Conflict of interest statement
Conflict of Interest: No conflict of interest was declared by the authors.
References
- Congest Heart Fail. 2004 May-Jun;10(3):144-9; quiz 150-1 - PubMed
- Eur J Heart Fail. 2007 Dec;9(12):1146-55 - PubMed
- Am J Pathol. 2001 Aug;159(2):513-25 - PubMed
- Hypertens Res. 2014 Oct;37(10):901-7 - PubMed
- Front Physiol. 2012 Jul 19;3:292 - PubMed
- Circulation. 2001 Sep 25;104(13):1464-70 - PubMed
- Kidney Int. 2004 May;65(5):1664-75 - PubMed
- Acta Pharmacol Sin. 2012 May;33(5):615-24 - PubMed
- Diabetes Metab. 2001 Nov;27(5 Pt 1):535-42 - PubMed
- Diabetologia. 2001 Feb;44(2):129-46 - PubMed
- Circ Res. 2003 Apr 18;92(7):785-92 - PubMed
- J Mol Cell Cardiol. 2007 Jan;42(1):234-46 - PubMed
- Pathol Biol (Paris). 2006 Sep;54(7):405-19 - PubMed
- Curr Opin Cardiol. 2004 Jul;19(4):336-40 - PubMed
- J Card Fail. 2005 Apr;11(3):191-5 - PubMed
- J Mol Med (Berl). 2005 Nov;83(11):876-86 - PubMed
- Circ Res. 2003 Apr 18;92(7):704-6 - PubMed
- N Engl J Med. 1988 May 19;318(20):1315-21 - PubMed
- Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2809-13 - PubMed
- Physiol Res. 2004;53(2):131-42 - PubMed
Publication Types